Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/22271
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYaylalı, Olga-
dc.contributor.authorYüksel, Doğangün-
dc.contributor.authorDoğu, Gamze Gököz-
dc.contributor.authorŞengöz, Tarık-
dc.contributor.authorYaren, Arzu-
dc.date.accessioned2019-08-20T06:44:10Z
dc.date.available2019-08-20T06:44:10Z
dc.date.issued2015-
dc.identifier.issn1619-7070-
dc.identifier.urihttps://hdl.handle.net/11499/22271-
dc.description.abstractAbstract Not Availableen_US
dc.language.isoenen_US
dc.publisherSPRINGERen_US
dc.relation.ispartofEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleThe response of metastatic lesions in renal cell carcinoma to tyrosine kinase inhibitors evaluated by F-18 FDG PET/CTen_US
dc.typeConference Objecten_US
dc.identifier.volume42en_US
dc.identifier.issue1en_US
dc.identifier.startpageS716
dc.identifier.startpageS716en_US
dc.identifier.endpageS716en_US
dc.authorid0000-0003-0983-2834-
dc.authorid0000-0001-8142-0362-
dc.authorid0000-0003-2621-7585-
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.identifier.wosWOS:000363013203284en_US
dc.identifier.scopusqualityQ1-
dc.ownerPamukkale University-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeConference Object-
item.languageiso639-1en-
item.fulltextNo Fulltext-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

Page view(s)

24
checked on Aug 24, 2024

Google ScholarTM

Check





Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.